Highlights
- Despite last week's minor pullback and some long-term trend deterioration, the US Risk Gauge remains in the upper half of mixed.
- The bulk of the weakness came from cyclical sectors of the market, but there was one area that excelled, Biotech.
"Biotech Now Among Leadership."
Last week, the IWM posted its first down week since July 28th, while the SPY notched just its second over the same stretch. Despite this pullback and some long-term trend deterioration, the. . .
